MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Health Systems, Economic Evaluations, Quality of Life
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,862 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,862 works in the cohort · of 4,299,418page 119 of 138

Labels cover 97 of 6,862 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,862 of 6,862 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affaboutunlabeled
A cost-utility analysis of combined durvalumab and tremelimumab in patients with refractory metastatic colorectal cancer (mCRC) and high plasma tumour mutation burden (pTMB): A Canadian Cancer Trials Group (CCTG) study.
Monish Ahluwalia, Ambika Parmar, Eric Xueyu Chen, Derek J. Jonker, Jonathan M. Loree, Christopher J. O’Callaghan +14 more
2021· article· en· Journal of Clinical Oncology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
VP190 A Review Of Best Practices In Five Mental Disorders In Youth
Ionela Gheorghiu, Alain Lesage, Leila Ben Amor, Patricia Conrod, Marie‐Claude Geoffroy, Janusz Kackzorowski +5 more
2017· review· en· International Journal of Technology Assessment in Health Care· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
The Cost of Quality in Diabetes
Ghany Ahmad
2017· book-chapter· en· Studies in health technology and informatics· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
affaboutunlabeled
Strategic Analytics to Drive Provincial Dialysis Capacity Planning
Neal Kaw, Somayeh Sadat, Ali Vahit Esensoy, Zhihui Liu, Sarah Jane Bastedo, Gihad Nesrallah
2017· book-chapter· en· Advances in healthcare information systems and administration book series· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
affaboutunlabeled
Market capitalism in cancer pharmaceuticals.
Henry Jacob Conter
2017· article· en· Journal of Clinical Oncology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
affvenueaboutunlabeled
Modélisation de l'efficacité de la prévention pour estimer le point de bascule de l'équité : quelle couverture des interventions préventives individuelles permet de réduire les effets des disparités socioéconomiques relatives au risque de diabète?
Douglas G. Manuel, Ho Th, Shirley Harper, GM Anderson, Josie Lynch, LC Rosella
2014· article· fr· Maladies chroniques et blessures au Canada· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
OP33 Treatment Of Mitral Insufficiency And Multicriteria Decision-Making
François Désy, Mireille Goetghebeur, M Nicolae, Laurie Lambert, Michèle de Guise
2019· article· en· International Journal of Technology Assessment in Health Care· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About